Founded in October 1963, Zhejiang Cancer Hospital (ZJCH) is one of the earliest four cancer specialized hospitals in China to maintain the highest standards of excellence in patient care, cancer prevention, research, education and rehabilitation and is ranked among the Top 10 Best Cancer Hospitals of China for 8 consecutive years. The hospital is ranked third in cancer hospitals of China for performance assessment of national public hospital, which is first published in 2020. Under the cooperation framework agreement signed by Zhejiang Provincial Government and the Chinese Academy of Sciences (CAS) in May 2019, the construction of Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences and Hangzhou Medical College has been underway with the tremendous support of Zhejiang Cancer Hospital. Since the cooperation agreement signed with Shaoxing Binhai New District Management Committee in September 2020, there are to co-build Cancer Hospital of the University of Chinese Academy of Sciences Shaoxing Campus.
To deliver the highest quality health care to each patient and to provide every employee with the best care available, bearing the social responsibility as a public hospital.
To achieve the highest standards of excellence as a cancer specialized hospital both nationwide and worldwide.
Compassion Harmony
Dedication Innovation
Founded in October 1963, Zhejiang Cancer Hospital (ZJCH) is one of the earliest four cancer specialized hospitals in China to maintain the highest standards of excellence in patient care, cancer prevention, research, education and rehabilitation and is ranked among the Top 10 Best Cancer Hospitals of China for 8 consecutive years. The hospital is ranked third in cancer hospitals of China for performance assessment of national public hospital, which is first published in 2020. Under the cooperation framework agreement signed by Zhejiang Provincial Government and the Chinese Academy of Sciences (CAS) in May 2019, the construction of Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences and Hangzhou Medical College has been underway with the tremendous support of Zhejiang Cancer Hospital. Since the cooperation agreement signed with Shaoxing Binhai New District Management Committee in September 2020, there are to co-build Cancer Hospital of the University of Chinese Academy of Sciences Shaoxing Campus.
The hospital is devoted to educating the brightest medical minds, providing undergraduate and postgraduate education through its National Post-doctoral Workstation, standardized training for residents and specialist nursing and is named the national residency institution for oncology. The hospital has 2,003 employees and is home to scores of renowned and influential experts and scholars with an extraordinary depth and breadth of medical experiences, including academician of the CAS, chief scientists of the 973 Project (the National Program on Key Basic Research Project), chief scientists of the National Key R&D Program, Yangtze River Scholars & Distinguished Professor, etc.
The hospital holds dynamic research programs. Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences (CAS), the first oncology research institution established by the CAS outside city of Beijing, stands as the first comprehensive national-level life health research institution introduced by Zhejiang Province. Key laboratories are established to advance the current understanding of tumor:
Ranked as one of the largest cancer specimen banks in China, the hospital sets up a biological specimen bank reserving over 300,000 specimens. In addition, a National Clinical Trials Center where physicians participating in plenty of clinical research protocols annually identify more-effective cancer therapies.
The hospital has made great efforts to promote international exchange and cooperation. It has carried out extensive and innovative collaboration in talent training, scientific research and clinical experience, etc. with international institutions America, Japan, German, Russia and Singapore. In 2016, the hospital was approved as Zhejiang International Science Technology Cooperation Base for Cancer Precision Treatment. International research teams have been set up to jointly carry out research projects on precision cancer diagnosis and treatment. Lots of mainstays are encouraged to go abroad for further study, participate in the authoritative international academic conference in the field of oncology to share their research achievements.
Last Updated: Sept. 2021